Report Detail

Summary:

Not all acne clears up with topical medications (i.e., creams, lotions, or gels).Oral medications, or those taken by mouth, work systemically (body-wide) to improve the skin from the inside out.
Market Insights
The research report studies the Oral Acne Medications market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
Due to the COVID-19 pandemic, the global Oral Acne Medications market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.
The global main companies of Oral Acne Medications include Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma and Lion, etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
The North America Oral Acne Medications market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Oral Acne Medications landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Antibiotics accounting for % of the Oral Acne Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Moderate Acne Treatment segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Antibiotics
Isotretinoin
Spironolactone
Combined Oral Contraceptives
Anti-androgen Agents
Others
Segment by Application
Moderate Acne Treatment
Severe Acne Treatment
Regional Scope
This segment of the report offers a thorough regional study of the global Oral Acne Medications market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
Galderma
Bausch Health
Teva
GlaxoSmithKline
Mylan
Almirall
Sun Pharma
Mayne Pharma
Lion
HUAPONT
Sine Pharma
Apotheco Pharmacy Group
Frequently Asked Questions
Which application segment captured the leading share in the Oral Acne Medications market?
How fragmented is the Oral Acne Medications market?
Which are the key growth drivers in the Oral Acne Medications market?
Which are the top strategies undertaken by the Oral Acne Medications market players?
Which technological trends are likely to affect the Oral Acne Medications market?
What is the expected Oral Acne Medications market size by 2028?
Which companies are dominating the Oral Acne Medications market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Oral Acne Medications market growth?
Which are the emerging companies in the Oral Acne Medications market?


Table of Contents

    1 Market Overview of Oral Acne Medications

    • 1.1 Oral Acne Medications Market Overview
      • 1.1.1 Oral Acne Medications Product Scope
      • 1.1.2 Oral Acne Medications Market Status and Outlook
    • 1.2 Global Oral Acne Medications Market Size Overview by Region 2017 VS 2021 VS 2028
    • 1.3 Global Oral Acne Medications Market Size by Region (2017-2028)
    • 1.4 Global Oral Acne Medications Historic Market Size by Region (2017-2022)
    • 1.5 Global Oral Acne Medications Market Size Forecast by Region (2023-2028)
    • 1.6 Key Regions, Oral Acne Medications Market Size (2017-2028)
      • 1.6.1 North America Oral Acne Medications Market Size (2017-2028)
      • 1.6.2 Europe Oral Acne Medications Market Size (2017-2028)
      • 1.6.3 Asia-Pacific Oral Acne Medications Market Size (2017-2028)
      • 1.6.4 Latin America Oral Acne Medications Market Size (2017-2028)
      • 1.6.5 Middle East & Africa Oral Acne Medications Market Size (2017-2028)

    2 Oral Acne Medications Market Overview by Type

    • 2.1 Global Oral Acne Medications Market Size by Type: 2017 VS 2021 VS 2028
    • 2.2 Global Oral Acne Medications Historic Market Size by Type (2017-2022)
    • 2.3 Global Oral Acne Medications Forecasted Market Size by Type (2023-2028)
    • 2.4 Antibiotics
    • 2.5 Isotretinoin
    • 2.6 Spironolactone
    • 2.7 Combined Oral Contraceptives
    • 2.8 Anti-androgen Agents
    • 2.9 Others

    3 Oral Acne Medications Market Overview by Application

    • 3.1 Global Oral Acne Medications Market Size by Application: 2017 VS 2021 VS 2028
    • 3.2 Global Oral Acne Medications Historic Market Size by Application (2017-2022)
    • 3.3 Global Oral Acne Medications Forecasted Market Size by Application (2023-2028)
    • 3.4 Moderate Acne Treatment
    • 3.5 Severe Acne Treatment

    4 Oral Acne Medications Competition Analysis by Players

    • 4.1 Global Oral Acne Medications Market Size by Players (2017-2022)
    • 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Acne Medications as of 2021)
    • 4.3 Date of Key Players Enter into Oral Acne Medications Market
    • 4.4 Global Top Players Oral Acne Medications Headquarters and Area Served
    • 4.5 Key Players Oral Acne Medications Product Solution and Service
    • 4.6 Competitive Status
      • 4.6.1 Oral Acne Medications Market Concentration Rate
      • 4.6.2 Mergers & Acquisitions, Expansion Plans

    5 Company (Top Players) Profiles and Key Data

    • 5.1 Galderma
      • 5.1.1 Galderma Profile
      • 5.1.2 Galderma Main Business
      • 5.1.3 Galderma Oral Acne Medications Products, Services and Solutions
      • 5.1.4 Galderma Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.1.5 Galderma Recent Developments
    • 5.2 Bausch Health
      • 5.2.1 Bausch Health Profile
      • 5.2.2 Bausch Health Main Business
      • 5.2.3 Bausch Health Oral Acne Medications Products, Services and Solutions
      • 5.2.4 Bausch Health Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.2.5 Bausch Health Recent Developments
    • 5.3 Teva
      • 5.3.1 Teva Profile
      • 5.3.2 Teva Main Business
      • 5.3.3 Teva Oral Acne Medications Products, Services and Solutions
      • 5.3.4 Teva Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.3.5 GlaxoSmithKline Recent Developments
    • 5.4 GlaxoSmithKline
      • 5.4.1 GlaxoSmithKline Profile
      • 5.4.2 GlaxoSmithKline Main Business
      • 5.4.3 GlaxoSmithKline Oral Acne Medications Products, Services and Solutions
      • 5.4.4 GlaxoSmithKline Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.4.5 GlaxoSmithKline Recent Developments
    • 5.5 Mylan
      • 5.5.1 Mylan Profile
      • 5.5.2 Mylan Main Business
      • 5.5.3 Mylan Oral Acne Medications Products, Services and Solutions
      • 5.5.4 Mylan Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.5.5 Mylan Recent Developments
    • 5.6 Almirall
      • 5.6.1 Almirall Profile
      • 5.6.2 Almirall Main Business
      • 5.6.3 Almirall Oral Acne Medications Products, Services and Solutions
      • 5.6.4 Almirall Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.6.5 Almirall Recent Developments
    • 5.7 Sun Pharma
      • 5.7.1 Sun Pharma Profile
      • 5.7.2 Sun Pharma Main Business
      • 5.7.3 Sun Pharma Oral Acne Medications Products, Services and Solutions
      • 5.7.4 Sun Pharma Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.7.5 Sun Pharma Recent Developments
    • 5.8 Mayne Pharma
      • 5.8.1 Mayne Pharma Profile
      • 5.8.2 Mayne Pharma Main Business
      • 5.8.3 Mayne Pharma Oral Acne Medications Products, Services and Solutions
      • 5.8.4 Mayne Pharma Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.8.5 Mayne Pharma Recent Developments
    • 5.9 Lion
      • 5.9.1 Lion Profile
      • 5.9.2 Lion Main Business
      • 5.9.3 Lion Oral Acne Medications Products, Services and Solutions
      • 5.9.4 Lion Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.9.5 Lion Recent Developments
    • 5.10 HUAPONT
      • 5.10.1 HUAPONT Profile
      • 5.10.2 HUAPONT Main Business
      • 5.10.3 HUAPONT Oral Acne Medications Products, Services and Solutions
      • 5.10.4 HUAPONT Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.10.5 HUAPONT Recent Developments
    • 5.11 Sine Pharma
      • 5.11.1 Sine Pharma Profile
      • 5.11.2 Sine Pharma Main Business
      • 5.11.3 Sine Pharma Oral Acne Medications Products, Services and Solutions
      • 5.11.4 Sine Pharma Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.11.5 Sine Pharma Recent Developments
    • 5.12 Apotheco Pharmacy Group
      • 5.12.1 Apotheco Pharmacy Group Profile
      • 5.12.2 Apotheco Pharmacy Group Main Business
      • 5.12.3 Apotheco Pharmacy Group Oral Acne Medications Products, Services and Solutions
      • 5.12.4 Apotheco Pharmacy Group Oral Acne Medications Revenue (US$ Million) & (2017-2022)
      • 5.12.5 Apotheco Pharmacy Group Recent Developments

    6 North America

    • 6.1 North America Oral Acne Medications Market Size by Country (2017-2028)
    • 6.2 United States
    • 6.3 Canada

    7 Europe

    • 7.1 Europe Oral Acne Medications Market Size by Country (2017-2028)
    • 7.2 Germany
    • 7.3 France
    • 7.4 U.K.
    • 7.5 Italy
    • 7.6 Russia

    8 Asia-Pacific

    • 8.1 Asia-Pacific Oral Acne Medications Market Size by Region (2017-2028)
    • 8.2 China
    • 8.3 Japan
    • 8.4 South Korea
    • 8.5 India
    • 8.6 Australia
    • 8.7 China Taiwan
    • 8.8 Indonesia

    9 Latin America

    • 9.1 Latin America Oral Acne Medications Market Size by Country (2017-2028)
    • 9.2 Mexico
    • 9.3 Brazil
    • 9.4 Argentina

    10 Middle East & Africa

    • 10.1 Middle East & Africa Oral Acne Medications Market Size by Country (2017-2028)
    • 10.2 Turkey
    • 10.3 Saudi Arabia
    • 10.4 UAE

    11 Oral Acne Medications Market Dynamics

    • 11.1 Oral Acne Medications Industry Trends
    • 11.2 Oral Acne Medications Market Drivers
    • 11.3 Oral Acne Medications Market Challenges
    • 11.4 Oral Acne Medications Market Restraints

    12 Research Finding /Conclusion

      13 Methodology and Data Source

      • 13.1 Methodology/Research Approach
        • 13.1.1 Research Programs/Design
        • 13.1.2 Market Size Estimation
        • 13.1.3 Market Breakdown and Data Triangulation
      • 13.2 Data Source
        • 13.2.1 Secondary Sources
        • 13.2.2 Primary Sources
      • 13.3 Disclaimer

      Summary:
      Get latest Market Research Reports on Oral Acne Medications. Industry analysis & Market Report on Oral Acne Medications is a syndicated market report, published as Global Oral Acne Medications Market Report, History and Forecast 2017-2028, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Oral Acne Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,350.00
      $6,700.00
      2,643.15
      5,286.30
      3,082.00
      6,164.00
      519,819.50
      1,039,639.00
      279,725.00
      559,450.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report